120
Views
2
CrossRef citations to date
0
Altmetric
Review

Progress in stem cell-derived technologies for hepatocellular carcinoma

Pages 81-92 | Published online: 03 May 2010

Figures & data

Figure 1 A general strategy for management of hepatocellular carcinoma based on tumor burden and the degree of liver disease. This algorithm depicts various treatment options that are used in the clinic depending upon the disease severity and the patient’s previous medical history.

Note: *Molecular and genetic prognostic markers from biopsy specimens may potentially alter existing selection criteria.
Abbreviations: AFP, alfa-fetoprotein; 3D XRT, three-dimensional conformal radiotherapy.
Figure 1 A general strategy for management of hepatocellular carcinoma based on tumor burden and the degree of liver disease. This algorithm depicts various treatment options that are used in the clinic depending upon the disease severity and the patient’s previous medical history.

Table 1 Liver stem/progenitor cells

Figure 2 Intra- and extrahepatic sources of stem cells from different origins that have been demonstrated to differentiate into hepatocyte-like cells.

Figure 2 Intra- and extrahepatic sources of stem cells from different origins that have been demonstrated to differentiate into hepatocyte-like cells.